Standout Papers
- Inhibitory effect of tumor cell–derived lactic acid on human T cells (2007)
- CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation (2003)
- Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation (2002)
- DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3+ conventional T cells (2007)
- Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host Disease (2014)
Immediate Impact
37 by Nobel laureates 16 from Science/Nature 73 standout
Citing Papers
De novo design of luciferases using deep learning
2023 StandoutNatureNobel
Heterostructural Nanoadjuvant CuSe/CoSe2 for Potentiating Ferroptosis and Photoimmunotherapy through Intratumoral Blocked Lactate Efflux
2023 Standout
Works of Matthias Edinger being referenced
Inhibitory effect of tumor cell–derived lactic acid on human T cells
2007 Standout
Noninvasive Assessment of Tumor Cell Proliferation in Animal Models
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Matthias Edinger | 5584 | 2274 | 2167 | 112 | 8.7k | |
| Jonathan S. Serody | 5293 | 2307 | 3191 | 183 | 8.8k | |
| Geoffrey S. Kansas | 4433 | 1427 | 1448 | 88 | 8.4k | |
| Marion Subklewe | 3822 | 1504 | 3702 | 164 | 8.2k | |
| Christoph Huber | 4913 | 786 | 3437 | 149 | 8.4k | |
| Otto Majdic | 6711 | 1423 | 1929 | 192 | 10.5k | |
| Kim E. Nichols | 6570 | 3431 | 3037 | 213 | 12.2k | |
| Robert C. Fuhlbrigge | 5083 | 717 | 2753 | 99 | 9.1k | |
| David Allman | 6597 | 1114 | 2322 | 112 | 10.9k | |
| Jeffrey J. Molldrem | 4022 | 3696 | 3365 | 159 | 8.4k | |
| Robert F. Todd | 4273 | 2279 | 1016 | 151 | 10.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...